Design Therapeutics (DSGN) Q1 2023 Earnings

9MayConfirmed
Aug 22
Nov 22
Q4 2022
Q1 2023
-0.36
-0.32
-0.29
-0.25

Details

Expected EPS
-0.36
Actual EPS
-0.35
Surprise EPS
0.01
Surprise Percent
+2.78%

Description

Design Therapeutics (DSGN) has reported earnings of -0.35 per share for Q1 2023.

0 Comments

Share your thoughts